This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Nov;10(11):1287-91.

doi: 10.1023/a:1008333901925.

Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA

E A Sausville¹, E Feigal

Affiliations

PMID: 10631454
DOI: 10.1023/a:1008333901925

Free article

Review

Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA

E A Sausville et al. Ann Oncol. 1999 Nov.

Free article

. 1999 Nov;10(11):1287-91.

doi: 10.1023/a:1008333901925.

Authors

E A Sausville¹, E Feigal

Affiliation

¹ Developmental Therapeutics Program, National Cancer Institute, NIH, Rockville, MD, USA. sausville@nih.gov

PMID: 10631454
DOI: 10.1023/a:1008333901925

No abstract available

PubMed Disclaimer

Similar articles

How does a drug get to phase III trials?
Reynolds T. Reynolds T. J Natl Cancer Inst. 2000 Oct 4;92(19):1555. doi: 10.1093/jnci/92.19.1555. J Natl Cancer Inst. 2000. PMID: 11018084 No abstract available.
Oncology's first Phase 0 trial.
Rowan K. Rowan K. J Natl Cancer Inst. 2009 Jul 15;101(14):978-9. doi: 10.1093/jnci/djp213. Epub 2009 Jul 7. J Natl Cancer Inst. 2009. PMID: 19584322 No abstract available.
Can single-patient investigational new drug studies hurry slow trains to the fast track?
Chenoweth D. Chenoweth D. Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4. Drug Discov Today. 2006. PMID: 16580594
Approaches to the development and marketing approval of drugs that prevent cancer.
Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, Mehta MU, Temeck JW, Schmidt WJ, Burke G, et al. Kelloff GJ, et al. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):1-10. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7894318 Review.
Development of investigational radiation modifiers.
Colevas AD, Brown JM, Hahn S, Mitchell J, Camphausen K, Coleman CN; Radiation Modifier Working Group of the National Cancer Institute. Colevas AD, et al. J Natl Cancer Inst. 2003 May 7;95(9):646-51. doi: 10.1093/jnci/95.9.646. J Natl Cancer Inst. 2003. PMID: 12734315 Review. No abstract available.

See all similar articles

Cited by

Balancing safety, effectiveness, and public desire: the FDA and cancer.
Conti R. Conti R. Issue Brief (Commonw Fund). 2003 Apr;(615):1-6. Issue Brief (Commonw Fund). 2003. PMID: 12693391 Free PMC article. No abstract available.
Global gene expression profiling in the study of multiple myeloma.
Shaughnessy JD Jr. Shaughnessy JD Jr. Int J Hematol. 2003 Apr;77(3):213-25. doi: 10.1007/BF02983777. Int J Hematol. 2003. PMID: 12731663 Review.
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents.
Sharma SV, Haber DA, Settleman J. Sharma SV, et al. Nat Rev Cancer. 2010 Apr;10(4):241-53. doi: 10.1038/nrc2820. Epub 2010 Mar 19. Nat Rev Cancer. 2010. PMID: 20300105 Review.
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.
Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA. Johnson JI, et al. Br J Cancer. 2001 May 18;84(10):1424-31. doi: 10.1054/bjoc.2001.1796. Br J Cancer. 2001. PMID: 11355958 Free PMC article.
ROADMAPS: An Online Database of Response Data, Dosing Regimens, and Toxicities of Approved Oncology Drugs as Single Agents to Guide Preclinical In Vivo Studies.
Hollingshead MG, Greenberg N, Gottholm-Ahalt M, Camalier R, Johnson BC, Collins JM, Doroshow JH. Hollingshead MG, et al. Cancer Res. 2022 Jun 15;82(12):2219-2225. doi: 10.1158/0008-5472.CAN-21-4151. Cancer Res. 2022. PMID: 35472132 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science